Literature DB >> 34309527

Dyshidrosiform pemphigoid due to nivolumab therapy.

Wakiko Hayashi1, Katsuhiro Yamada1, Kenta Kumagai2, Michihiro Kono1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34309527     DOI： 10.1684/ejd.2021.4052

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  1 in total

1.  Hemidesmosomal Reactivity and Treatment Recommendations in Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid-A Retrospective, Monocentric Study.

Authors:  Franziska Schauer; David Rafei-Shamsabadi; Shoko Mai; Yosuke Mai; Kentaro Izumi; Frank Meiss; Dimitra Kiritsi
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.